妙可藍多(600882.SH)擬定增募資不超8.9億元 由內蒙蒙牛認購3.15億元
格隆匯3月24日丨妙可藍多(600882.SH)披露2020年非公開發行A股股票預案,擬非公開發行股票募集資金總額不超過8.9億元,發行股票數量為不超過5870.7123萬股,未超過此次發行前上市公司總股本的30%;發行價為15.16元/股。
其中,東秀實業與內蒙蒙牛分別認購5.75億元、3.15億元。扣除發行費用後,約4.42億元用於妙可藍多上海第二工廠改擴建項目,約2.51億元用於吉林中新食品區奶酪加工建設項目,1.97億元用於廣澤乳業特色乳品產業升級改造項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.